During the past decade, The First People'S Hospital of Shenyang conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The First People'S Hospital of Shenyang" #1 sponsor was "Angde Biotech Pharmaceutical Co., Ltd." with 1 trials, followed by "Beijing Tiantan Hospital" with 1 trials sponsored, "Ji Xunming,MD,PhD" with 1 trials sponsored, "Peking University Third Hospital" with 1 trials sponsored and "Shenyang Northern Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The First People'S Hospital of Shenyang" #1 collaborator was "Ankang City Central Hospital" with 1 trials as a collaborator, "Beihua University" with 1 trials as a collaborator, "Beijing Chuiyangliu Hospital(Beijing Minimally Invasive Hospital)" with 1 trials as a collaborator, "Beijing Shijitan Hospital,the 9th Clinical Medical College of Peking university" with 1 trials as a collaborator and "Beijing Sihuan Pharmaceutical Co. Ltd." with 1 trials as a collaborator. Other collaborators include 54 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "The First People'S Hospital of Shenyang" are "Acute Ischemic Stroke" (2 trials), "Acute Ischaemic Stroke" (1 trials), "Adverse Drug Reaction" (1 trials), "Cinepazide" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "The First People'S Hospital of Shenyang" in a lesser frequency.

Most popular intervention types in "The First People'S Hospital of Shenyang" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Aspirin simulation agent" (1 trials), "Doctormate® (200mmHg)" (1 trials), "Doctormate® (60mmHg)" (1 trials) and "Injection of recombinant human tissue plasminogen kinase derivatives" (1 trials). Other intervention names were less common.

The vast majority of trials in "The First People'S Hospital of Shenyang" are 6 trials for "All" genders.

Currently, there are NaN active trials in "The First People'S Hospital of Shenyang". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in The First People'S Hospital of Shenyang, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The First People'S Hospital of Shenyang, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".